Publications by authors named "Gert van Assche"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

272

Total Likes

3

Extended Reach

34,949

Social Features

4
I
Impact of endoscopy system, high definition, and virtual chromoendoscopy in daily routine colonoscopy: a randomized trial.
Philip Roelandt, Ingrid Demedts, Hilde Willekens, Talat Bessissow, Lieve Braeye, Georges Coremans, Pieter-Jan Cuyle, Marc Ferrante, Anne-Marie Gevers, Martin Hiele

Endoscopy· March 2019

Videos about Article: user

1 2 3

View All Article and Social Media Activity
M
Magnetic Resonance Enterography and Histology in Patients With Fibrostenotic Crohn's Disease: A Multicenter Study.
Alexandre Coimbra, Jordi Rimola, Miriam Cuatrecasas, Gert De Hertogh, Gert Van Assche

Clin Transl Gastroenterol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Bowel Disease-related Behaviours [IBD-Bx] Questionnaire: Development, Validation and Prospective Associations with Fatigue.
Marta Walentynowicz, Iris van de Pavert, Liselotte Fierens, Sofie Coenen, Johan W S Vlaeyen, Gert Van Assche

J Crohns Colitis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing capnography to help improve patient safety during procedural sedation: quality improvement in a high-volume gastroenterology department.
Raf Bisschops, Rhodri Saunders, Christophe Dooms, Ilse Hoffman, Schalk van der Merwe, Gert Van Assche

Eur J Gastroenterol Hepatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update.
Emanuel Burri, Michel H Maillard, Alain M Schoepfer, Frank Seibold, Gert Van Assche

Digestion· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine.
David Laharie, Arnaud Bourreille, Julien Branche, Matthieu Allez, Yoram Bouhnik, Gert van Assche

Clin Gastroenterol Hepatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing Countries.
Richard B Gearry, Andrew M McCombie, Morten Vatn, David T Rubin, Flavio Steinwurz, Gert Van Assche

Inflamm Intest Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.
Pauline Rivière, Séverine Vermeire, Marie Irles-Depe, Gert Van Assche, Paul Rutgeerts

Clin Gastroenterol Hepatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium.
Brecht Creyns, Inge Jacobs, Bram Verstockt, Jonathan Cremer, Vera Ballet, Gert Van Assche

Front Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worries and concerns of inflammatory bowel disease (IBD) patients in Belgium - a validation of the Dutch rating form.
Marta Walentynowicz, Iris Van de Pavert, Sofie Coenen, Liselotte Fierens, Johan Vlaeyen, Gert Van Assche

Scand J Gastroenterol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis.
Heinfried H Radeke, Jürgen Stein, Gert Van Assche, Gerhard Rogler, Peter L Lakatos

Inflamm Intest Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients.
Iris Detrez, Debby Thomas, Kristel Van Steen, Vera Ballet, Miet Peeters, Gert Van Assche

J Clin Gastroenterol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis.
Omoniyi J Adedokun, Zhenhua Xu, Colleen Marano, Chris O'Brien, Philippe Szapary, Gert Van Assche

Clin Gastroenterol Hepatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells.
Brecht Creyns, Jonathan Cremer, Gert De Hertogh, Louis Boon, Marc Ferrante, Gert Van Assche

Immun Inflamm Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis.
Mitchell R K L Lie, Joany E Kreijne, Gerard Dijkstra, Mark Löwenberg, Gert van Assche

Clin Gastroenterol Hepatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
William J Sandborn, Brian G Feagan, Edward V Loftus, Laurent Peyrin-Biroulet, Gert Van Assche

Gastroenterology· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases.
Bram Verstockt, Sare Verstockt, Marisol Veny, Jonas Dehairs, Kaline Arnauts, Gert Van Assche

Clin Gastroenterol Hepatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.
Michiel Bronswijk, Annick Moens, Matthias Lenfant, Sophie Tops, Griet Compernolle, Gert Van Assche

Inflamm Bowel Dis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients.
Bram Verstockt, Evelien Mertens, Erwin Dreesen, An Outtier, Maja Noman, Gert Van Assche

J Crohns Colitis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of concept study for patients with inflammatory bowel disease in remission on biological therapy.
Sofie Coenen, Egon Nijns, Ellen Weyts, Patricia Geens, Bart Van den Bosch, Gert Van Assche

Scand J Gastroenterol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor.
Magali de Bruyn, Randy Ringold, Erik Martens, Marc Ferrante, Gert Van Assche

J Crohns Colitis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.
Michiel Bronswijk, Annick Moens, Matthias Lenfant, Sophie Tops, Griet Compernolle, Gert Van Assche

Inflamm Bowel Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis.
Damián García-Olmo, Gert Van Assche, Ignacio Tagarro, Mary Carmen Diez, Marie Paule Richard

Adv Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.
Bram Verstockt, Charlotte Claeys, Gert De Hertogh, Gert Van Assche, Albert Wolthuis

United European Gastroenterol J· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Bowel Disease (IBD)-A Textbook Case for Multi-Centric Banking of Human Biological Materials.
Isabelle Cleynen, Loes Linsen, Sare Verstockt, Bram Verstockt, Vera Ballet, Gert Van Assche

Front Med (Lausanne)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Bruce E Sands, William J Sandborn, Remo Panaccione, Christopher D O'Brien, Hongyan Zhang, Gert Van Assche

N Engl J Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis